Back to all webinars
Relapsed/refractory Waldenström’s macroglobulinemia: Key considerations for managing pre-treated patients
Christian Buske, Ramón García-Sanz, Véronique Leblond and Alessandra Tedeschi focus on treatment for patients with relapsed and refractory Waldenström’s macroglobulinemia, and look to the future of Waldenström’s macroglobulinemia treatment.
Speakers
First- and second-line treatment of a patient with WM
No entries
What is the current approach for patients that are refractory to, or experience relapse, following first-line treatment?
Fast-forward to:
WM remains incurable and so it is vital to have optimal strategies for care of relapsed patients
61ae3ddb3ebc500dae6c9059
The influence of guidelines on treatment for relapsed WM
61ae3f403ebc500dae6c906d
The role of classical chemotherapy in relapsed WM
61ae41342fc9050db56f83fa
The role of stem cell transplantation in relapsed WM
61ae4686f8742a0daf9e3143
Chemotherapy-free treatment options for relapsed WM
61ae49721b44ef0dbc7089f4
Can next-generation BTK inhibitors provide benefits over ibrutinib for relapsed WM?
61ae5b803ebc500dae6c90c1
What treatment options beyond BTK inhibitors are on the horizon?
61ae68aa1b44ef0dbc708a3d
Summary and key challenges in relapsed WM treatment
61ae6ba6f8742a0daf9e31c0
Case study - A patient with WM refractory to first-line treatment
No entries
Case study - A patient with relapsed WM
No entries
Cases study panel discussion
Fast-forward to:
What is your definition of a refractory WM patient?
61af07443ebc500dae6c91dc
How do you tailor your treatment for relapsed/refractory WM according to mutational status?
61af0bb22fc9050db56f8573
How do you tailor your treatment for relapsed/refractory WM according to rIPSS scores?
61af135f3ebc500dae6c920f
For WM patients who relapse on ibrutinib, what is your next favoured treatment option?
61af10ae1b44ef0dbc708b41
Open panel discussion
No entries
Q&A
Fast-forward to:
How would you treat a patient who has developed intolerance to ibrutinib and rituximab?
61af18982fc9050db56f85aa
Should BTK inhibitors be used for younger patients before stem cell transplantation?
61af24a9f8742a0daf9e330c
How would you treat an 82-year old female who has failed three lines of treatment with DRC, ibrutinib and bendamustine, respectively?
61af1bd72fc9050db56f85ba